المؤلفون: Almeman AA; Clinical Pharmacology and Therapeutics Department, Qassim University, Buraydah, Qassim, Saudi Arabia., Beshir YA; Interventional Cardiology Department, Prince Sultan Cardiac Center, Buraydah, Qassim, Saudi Arabia., Aldosary AH; Family and Community Medicine Department, Unaizah College of Medicine and Medical Sciences, Qassim University, Qassim, Saudi Arabia.

المصدر: Current drug safety [Curr Drug Saf] 2019; Vol. 14 (1), pp. 27-30.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Saif Zone, Sharjah, U.A.E. Country of Publication: United Arab Emirates NLM ID: 101270895 Publication Model: Print Cited Medium: Internet ISSN: 2212-3911 (Electronic) Linking ISSN: 15748863 NLM ISO Abbreviation: Curr Drug Saf Subsets: MEDLINE

مواضيع طبية MeSH: Bisoprolol/*therapeutic use , Cardiovascular Diseases/*blood , Cardiovascular Diseases/*drug therapy , Glucose/*metabolism , Lipids/*blood , Metoprolol/*therapeutic use, Antihypertensive Agents/adverse effects ; Antihypertensive Agents/therapeutic use ; Bisoprolol/adverse effects ; Cross-Sectional Studies ; Electrocardiography/drug effects ; Female ; Humans ; Male ; Metoprolol/adverse effects ; Middle Aged ; Retrospective Studies ; Treatment Outcome